The CDC has highlighted the alarming rate at which antibiotic-resistant bacteria infect individuals in the U.S., with over two million infections reported annually, leading to around 23,000 deaths. Recognizing the gravity of this global public health threat, Light Line Medical, Inc. (LLM) developed a patented visible-light technology platform designed to combat healthcare-associated infections. Utilizing non-UV visible light, LLM's innovative approach eradicates bacteria and prevents biofilm formation within catheters. Notably, LLM's products, comprising a reusable light-generating unit, a disposable fiber optic, and a fiber introducer, are designed to seamlessly integrate with standard catheters and endotracheal tubes. LLM's range of applications spans the Peritoneal Dialysis, Urinary, Respiratory, and Vascular Catheters sectors. Particularly significant is the potential shift in preference from Hemodialysis to the safer Peritoneal Dialysis due to LLM's infection prevention capabilities. With their Respiratory PhotoDisinfection System™, the company also targets the reduction of ventilator-associated pneumonia, a prevalent infection in ICU settings. Ultimately, Light Line's groundbreaking technology holds the promise of redefining catheter care, aiming to offer patients the highest standard in catheter-related treatments.

---

+ more.